RU2044541C1 - Способ получения лечебного средства для трансдермального применения - Google Patents

Способ получения лечебного средства для трансдермального применения Download PDF

Info

Publication number
RU2044541C1
RU2044541C1 SU904830921A SU4830921A RU2044541C1 RU 2044541 C1 RU2044541 C1 RU 2044541C1 SU 904830921 A SU904830921 A SU 904830921A SU 4830921 A SU4830921 A SU 4830921A RU 2044541 C1 RU2044541 C1 RU 2044541C1
Authority
RU
Russia
Prior art keywords
estrogen
applying
layer
active substance
suspension
Prior art date
Application number
SU904830921A
Other languages
English (en)
Russian (ru)
Inventor
Гюнтер Клеменс
Тоибер Ульрих
Шмидт-Голльвитцер Карин
Ридль Ютта
Так Иоханнес-Вильхельм
Original Assignee
Шеринг Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP1989/001200 external-priority patent/WO1990004397A1/de
Application filed by Шеринг Аг filed Critical Шеринг Аг
Application granted granted Critical
Publication of RU2044541C1 publication Critical patent/RU2044541C1/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SU904830921A 1989-03-29 1990-06-26 Способ получения лечебного средства для трансдермального применения RU2044541C1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DEP3910578.4 1989-03-29
DE19893910578 DE3910578A1 (de) 1989-03-29 1989-03-29 Mittel zur transdermalen applikation enthaltend gestoden
PCT/EP1989/001200 WO1990004397A1 (de) 1988-10-27 1989-10-11 Mittel zur transdermalen applikation enthaltend gestoden

Publications (1)

Publication Number Publication Date
RU2044541C1 true RU2044541C1 (ru) 1995-09-27

Family

ID=6377622

Family Applications (1)

Application Number Title Priority Date Filing Date
SU904830921A RU2044541C1 (ru) 1989-03-29 1990-06-26 Способ получения лечебного средства для трансдермального применения

Country Status (5)

Country Link
CZ (1) CZ277870B6 (pl)
DE (1) DE3910578A1 (pl)
PL (2) PL162410B1 (pl)
RU (1) RU2044541C1 (pl)
SK (1) SK608989A3 (pl)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008136699A1 (fr) * 2007-05-04 2008-11-13 Igor Alexandrovich Bazikov Patch transdermique à microcapsules et procédé de fabrication correspondant
US10532033B2 (en) 1999-07-02 2020-01-14 Lts Lohmann Therapie-Systeme Ag Microreservoir system based on polysiloxanes and ambiphilic solvents

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018774A1 (de) * 1992-03-21 1993-09-30 Entec Gesellschaft Für Endokrinologische Technologie M.B.H. Verwendung von östriol zur behandlung von klimakterischer osteoporose
DE19526864A1 (de) * 1995-07-22 1997-01-23 Labtec Gmbh Hormonpflaster
DE10019171A1 (de) * 2000-04-07 2001-10-18 Schering Ag Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Европейский патент N 0279977, А2, кл. A 61K 31/57, 1988. *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10532033B2 (en) 1999-07-02 2020-01-14 Lts Lohmann Therapie-Systeme Ag Microreservoir system based on polysiloxanes and ambiphilic solvents
US10709669B2 (en) 1999-07-02 2020-07-14 Lts Lohmann Therape-Systeme Ag Microreservoir system based on polysiloxanes and ambiphilic solvents
WO2008136699A1 (fr) * 2007-05-04 2008-11-13 Igor Alexandrovich Bazikov Patch transdermique à microcapsules et procédé de fabrication correspondant

Also Published As

Publication number Publication date
PL282033A1 (en) 1991-03-11
PL162410B1 (pl) 1993-11-30
DE3910578A1 (de) 1990-10-04
SK278438B6 (en) 1997-05-07
PL287526A1 (en) 1991-10-21
CZ277870B6 (en) 1993-06-16
SK608989A3 (en) 1997-05-07
PL162400B1 (pl) 1993-11-30
CZ608989A3 (en) 1993-02-17

Similar Documents

Publication Publication Date Title
JP3238389B2 (ja) ゲストデン含有の経皮適用のための薬剤
AU687013B2 (en) Transdermal application agent containing 3-keto-desogestrel
KR100392435B1 (ko) 성스테로이드를함유하는경피치료시스템
US5858394A (en) Agent for transdermal administration that contains gestodene esters
DD286293A5 (de) Mittel zur transdermalen applikation enthaltend gestoden
RU2044541C1 (ru) Способ получения лечебного средства для трансдермального применения
JPH09508911A (ja) デソゲストレルを含有する経皮適用剤
JPH11509222A (ja) １３−エチル−１７β−ヒドロキシ−１１−メチレン−１８，１９−ジノル−１７α−プレグン−４−エン−２０−イン−３−オンのエステルを含む経皮投与のための剤
JP3034600B2 (ja) ロリプラムを含有する皮膚浸透移行性適用剤
JPH09510697A (ja) １４α，１７α−エタノエストラ−１，３，５（１０）−トリエン−３，１７β−ジオールを含有する経皮投与のための薬剤
DE19613698A1 (de) Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons
AU724308B2 (en) Transdermal therapeutic systems that contain sex steroids
CA2182188A1 (en) Agent, intended for transdermal administration, containing 14.alpha.,17.alpha.-ethanoestra-1,3,5(10)-triene-3,17.beta.-diol
HUT74616A (en) Agent, intended for transdermal administration, containing 14alfa, 17alfa-ethanoestra-1,3,5(10)-triene-3,17beta-diol